Search Results - "Ohnsman, Christina"

OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy by Huang, Wei Chieh, Ohnsman, Christina M, Atiskova, Yevgeniya, Falabella, Paulo, Spitzer, Martin S, Schulz, Angela, Dulz, Simon

“…Bilateral progressive, symmetrical loss of central retinal thickness (CRT) has been described in neuronal ceroid lipofuscinosis type 2 (CLN2) disease. This…”
Get full text

Exclusion of students with conjunctivitis from school: policies of state departments of health by Ohnsman, Christina M

“…To use current state department of health regulations regarding exclusion of students with conjunctivitis from school as a starting point in developing uniform…”
Get full text

Laboratory data and statistical evidence in fluoroquinolone study by O'Callaghan, Richard, PhD, Ohnsman, Christina, MD, Song, Jenny, MD, MS

Get full text

Characterizing visual function in children with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2): The caregiver perspective by Phillips, Dawn, Fernandez, Vivian, Ohnsman, Christina

Get full text

Loss of visual function associated with photoreceptor degeneration in CLN2 disease by Ohnsman, Christina, Huang, Wei Chieh, Atiskova, Yevgeniya, Wildner, Jan, Falabella, Paulo, Schulz, Angela, Dulz, Simon

Get full text

Pilot study of novel optokinetic nystagmus-based visual acuity test in children with CLN2 disease by Ohnsman, Christina, Atiskova, Yevgeniya, Wildner, Jan, Konig, Boaz, Schulz, Angela, Dulz, Simon

Get full text

Interim results from the first-in-human intracisternal dosing of RGX-181 investigational AAV9 gene therapy in a child with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) by de Souza, Carolina Fischinger Moura, Alves, Tamires, Duarte, Juliana, Burke, Jenna, Chan, Gary, Higgins, Mikayla, Falabella, Paulo, Phillips, Dawn, Ohnsman, Christina, Giugliani, Roberto

Get full text

Characterization of retinal degeneration phenotype in classic CLN2 disease using OCT biomarkers and an retinal model by Ohnsman, Christina, Kim, Kwi Hye, Huang, Wei Chieh, Corti, Serena, Achberger, Kevin, Liebau, Stefan, Loskill, Peter, Atiskova, Yevgeniya, Falabella, Paulo, Buss, Nicholas, Schulz, Angela, Dulz, Simon

Get full text

Characterization of retinal degeneration phenotype in classic CLN2 disease using OCT biomarkers and an in vitro retinal model by Ohnsman, Christina, Kim, Kwi Hye, Huang, Wei Chieh, Corti, Serena, Achberger, Kevin, Liebau, Stefan, Loskill, Peter, Atiskova, Yevgeniya, Falabella, Paulo, Buss, Nicholas, Schulz, Angela, Dulz, Simon

Get full text

RGX-381: Interim results from the first-in-human clinical trial of an investigational gene therapy for the treatment of ocular manifestations of CLN2 Batten disease by Ohnsman, Christina, Bailey, Alexander M., Huang, Wei, Buss, Nicholas, Kim, Kwi Hye, Chan, Gary, Burke, Jenna, Phillips, Dawn, Higgins, Mikayla, Henderson, Robert H., Gissen, Paul, Schulz, Angela, Pakola, Stephen, Falabella, Paulo

Get full text

Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis by Ohnsman, Christina, Ritterband, David, O’Brien, Terrence, Girgis, Dalia, Kabat, Al

“…ABSTRACT Objective: To examine in vitro resistance to azithromycin and moxifloxacin in bacterial conjunctivitis isolates. Methods: MIC90s (Minimum Inhibitory…”
Get full text